Glycemic dysregulation might reflect poor pancreatic β-cell function and the inadequate release of endogenous insulin; therefore, hyperglycemia and high GV would be more pronounced in patients with type 2 diabetes with worse glucose control and longer disease duration [15]. This evidence concerns the gene INS and Hyperglycemia.